On June 30, ECHA published a revised list of active substances approved for use in treated articles.
The scientific journal Toxics published our research on the evaluation of endocrine potential using artificial intelligence.
Scientific Committee on Consumer Safety adopted 12th revision of Notes of guidance for the testing of cosmetic ingredients and their safety evaluation.
New hazard classes for Endocrine disruptors (ED) and persistent substances (PBT, vPvB, PM, vPvM) were introduced.
The European Chemicals Agency (ECHA) has published recommended guidelines for conducting an analysis of alternatives (AoA) for active substances that are candidates for substitution.
By January 1, 2024, all manufacturers of biocidal products containing Chrysanthemum cinerariaefolium Extract must submit an application for authorization if they wish to continue selling their products.
The court considered that the Commission made an obvious error in assessing the reliability and acceptability of the study on which the classification was based, and therefore declared the Commission's regulation from 2019 null and void in this part.
The list of allergens that must be listed on the label will increase to more than 80 substances. Companies will have to either adjust their formulations or change the labeling of a large volume of products in the coming years.
The guidelines are used to demonstrating the effectiveness of biocidal products in the authorization process. However, the requirements defined in the document are also used by the Competent authorities in registration process in transitional period.
ECHA published the Biocidal Products Committee work programme for 2020, specifying substances with authorisation date expected to be published in 2020.